Supporting Precision Dosing in Drug Labeling
Michael Neely(University of Southern California), Daniel González(University of North Carolina at Chapel Hill), Elizabeth A. Lakota(Vertex Pharmaceuticals (United States)), Amelia N. Deitchman(University of California, San Francisco), Sean N. Avedissian(Nebraska Medical Center), Nikolas J. Onufrak(University of North Carolina at Chapel Hill), Marc H. Scheetz(Midwestern University)
Cited by 9
Related Papers
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
|Cell Reports|2021|266
Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents
|Antimicrobial Agents and Chemotherapy|2005|239